Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for SINT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 4.83M
March 31, 2026 0.904M
December 31, 2025 2.929M
September 30, 2025 4.068M
June 30, 2025 3.988M
March 31, 2025 6.092M
December 31, 2024 3.894M
September 30, 2024 5.581M
June 30, 2024 8.846M
March 31, 2024 9.926M
December 31, 2023 8.772M
September 30, 2023 10.69M
June 30, 2023 13.81M
March 31, 2023 15.94M
December 31, 2022 5.704M
September 30, 2022 9.415M
June 30, 2022 12.05M
March 31, 2022 14.45M
December 31, 2021 17.73M
September 30, 2021 19.24M
June 30, 2021 21.48M
March 31, 2021 23.60M
December 31, 2020 25.80M
September 30, 2020 27.54M
June 30, 2020 19.20M
Date Value
March 31, 2020 11.21M
December 31, 2019 5.202M
September 30, 2019 6.028M
June 30, 2019 6.44M
March 31, 2019 6.77M
December 31, 2018 8.399M
September 30, 2018 8.09M
June 30, 2018 11.31M
March 31, 2018 5.986M
December 31, 2017 5.442M
September 30, 2017 10.44M
June 30, 2017 12.27M
March 31, 2017 13.91M
December 31, 2016 11.24M
September 30, 2016 17.32M
June 30, 2016 9.753M
March 31, 2016 10.93M
December 31, 2015 14.23M
September 30, 2015 -1.717M
June 30, 2015 8.161M
March 31, 2015 3.181M
December 31, 2014 6.907M
September 30, 2014 11.96M
June 30, 2014 14.86M
March 31, 2014 20.46M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ClearPoint Neuro, Inc. 10.78M
Abbott Laboratories 51.11B
AngioDynamics, Inc. 170.82M
Alphatec Holdings, Inc. 11.53M
AtriCure, Inc. 516.43M

Shareholders Equity (Quarterly) Related Metrics